Wo ist der Beweis? Plädoyer für eine evidenzbasierte Medizin ...
Wo ist der Beweis? Plädoyer für eine evidenzbasierte Medizin ...
Wo ist der Beweis? Plädoyer für eine evidenzbasierte Medizin ...
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
Literatur 24515. Thornton H. The patient’s role in research. [Vortrag, gehalten anlässlich <strong>der</strong> TheLancet «Challenge of Breast Cancer» Conference, Brügge, April 1994.] In: HealthCommittee Third Report. Breast cancer services. Volume II. Minutes of evidenceand appendices. London: HMSO, July 1995, S. 112–114.16. Concorde Coordinating Committee. Concorde: MRC/ANRS randomised double-blindcontrolled trial of immediate and deferred zidovudine in symptom-freeHIV infection. Lancet 1994; 343: 871–881.17. Perehudoff K, Alves TL. Patient and consumer organisations at the EuropeanMedicines Agency: financial disclosure and transparency. Amsterdam: HealthAction International, 2010. Zugänglich unter: www.haieurope.org.18. Herxheimer A. Relationships between the pharmaceutical industry and patients’organisations. BMJ 2003; 326: 1208–1210.19. Consumers’ Association. Who’s injecting the cash? Which? 2003, April, S. 24–25.20. Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke: consumer involvementin design of new randomised controlled trial. BMJ 2002; 325:415–417.21. Donovan J, Mills N, Smith M, et al for the ProtecT Study Group. Quality improvementreport: improving design and conduct of randomised trials by embeddingthem in qualitative research: ProtecT (prostate testing for cancer andtreatment) study. BMJ 2002; 325: 766–770.Kapitel 121. Edwards A, Elwyn G, Atwell C, et al. Shared decision making and risk communicationin general practice – a study incorporating systematic literature reviews,psychometric evaluation of outcome measures, and quantitative, qualitative andhealth economic analyses of a cluster randomised trial of professional skill development.Report to Health in Partnership programme, UK Department ofHealth. Cardiff: Department of General Practice. University of Wales College ofMedicine, 2002.2. Farrell C, ed. Patient and public involvement in health: The evidence for policyimplementation. A summary of the results of the Health in Partnership researchprogramme. London: Department of Health Publications, April 2004. Zugänglichunter: www.dh.gov.uk/en/Publicationsandstat<strong>ist</strong>ics/Publications/Publications-PolicyAndGuidance/DH_4082332.3. In Anlehnung an: Marshall T. Prevention of cardiovascular disease. Risk andbenefit calculator. Zugänglich unter: www.haps.bham.ac.uk/publichealth/cardiovascular/index.shtml.4. Evans I, Thornton H. Transparency in numbers: the dangers of stat<strong>ist</strong>ical illiteracy.Journal of the Royal Society of Medicine 2009; 102: 354–356.5. Irwig L, Irwig J, Trevena L, et al. Smart health choices: making sense of health advice.London: Hammersmith Press, 2008.6. Salzburg Global Seminar Website: www.salzburgglobal.org.7. Salzburger Erklärung zur partizipativen Entscheidungsfindung: Salzburg GlobalSeminar. BMJ 2011; 342: d1745. Zugänglich unter: www.bmj.com/content/342/bmj.d1745.full.© 2013 by Verlag Hans Huber, Hogrefe AG, BernDieses Dokument <strong>ist</strong> nur <strong>für</strong> den persönlichen Gebrauch bestimmt und darf in k<strong>eine</strong>r Form vervielfältigt und an Dritte weitergegeben werden.Aus: Imogen Evans, Hazel Thornton, Iain Chalmers, Paul Glasziou; <strong>Wo</strong> <strong>ist</strong> <strong>der</strong> <strong>Beweis</strong>? – <strong>Plädoyer</strong> <strong>für</strong> <strong>eine</strong> <strong>evidenzbasierte</strong> <strong>Medizin</strong>. 1. Auflage.
Change language